Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Annals of Behavioral Medicine
Erschienen in: Annals of Behavioral Medicine 1/2011

01.02.2011 | Original Article

A Randomized Controlled Trial of Behavioral Weight Loss Treatment Versus Combined Weight Loss/Depression Treatment Among Women with Comorbid Obesity and Depression

verfasst von: Jennifer A. Linde, Ph.D., Gregory E. Simon, M.D., M.P.H, Evette J. Ludman, Ph.D., Laura E. Ichikawa, M.S, Belinda H. Operskalski, M.P.H, David Arterburn, M.D., Paul Rohde, Ph.D., Emily A. Finch, M.A, Robert W. Jeffery, Ph.D.

Erschienen in: Annals of Behavioral Medicine | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

Obesity is associated with clinical depression among women. However, depressed women are often excluded from weight loss trials.

Purpose

This study examined treatment outcomes among women with comorbid obesity and depression.

Methods

Two hundred three (203) women were randomized to behavioral weight loss (n = 102) or behavioral weight loss combined with cognitive-behavioral depression management (n = 101).

Results

Average participant age was 52 years; mean baseline body mass index was 39 kg/m2. Mean Patient Health Questionnaire and Hopkins Symptom Checklist (SCL-20) scores indicated moderate to severe baseline depression. Weight loss and SCL-20 changes did not differ between groups at 6 or 12 months in intent-to-treat analyses (p = 0.26 and 0.55 for weight, p = 0.70 and 0.25 for depressive symptoms).

Conclusions

Depressed obese women lost weight and demonstrated improved mood in both treatment programs. Future weight loss trials are encouraged to enroll depressed women.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Carpenter KM, Hasin DS, Allison DB, Faith MS. Relationships between obesity and DSM-IV major depressive disorder, suicidal ideation, and suicide attempts: Results from a general population survey. Am J Public Health 2000; 90: 251-7.CrossRefPubMed
2.
Simon GE, Von Korff M, Saunders K et al. Association between obesity and psychiatric disorders in the US adult population. Arch Gen Psychiat 2006; 63: 824-30.CrossRefPubMed
3.
Thande NK, Hurstak EE, Sciacca RE, Giardina EGV. Management of obesity: A challenge for medical training and practice. Obes 2008; 17: 107-13.
4.
Goldstein LT, Goldsmith SJ, Anger K, Leon AC. Psychiatric symptoms in clients presenting for commercial weight reduction treatment. Int J Eat Disord 1996; 20: 191-7.CrossRefPubMed
5.
Clark MM, Niaura R, King TK, Pera V. Depression, smoking, activity level, and health status: Pretreatment predictors of attrition in obesity treatment. Addict Behav 1996; 21: 509-313.CrossRefPubMed
6.
Linde JA, Jeffery RW, Levy RL et al. Binge eating disorder, weight control self-efficacy, and depression in overweight men and women. Int J Obes Relat Metab Disord 2004; 28: 418-25.CrossRefPubMed
7.
McGuire MT, Wing RR, Klem ML, Lang W, Hill JO. What predicts weight regain in a group of successful weight losers? J Consult Clin Psychol 1999; 67: 177-85.CrossRefPubMed
8.
Anderson RE, Wadden TA, Bartlett SJ, Zemel B, Verde TJ, Franckowiak SC. Effects of lifestyle activity vs. structured aerobic exercise in obese women: A randomized trial. JAMA 1999; 281: 335-40.CrossRef
9.
Wirth A, Krause J. Long-term weight loss with sibutramine: A randomized controlled trial. JAMA 2001; 286: 1331-9.CrossRefPubMed
10.
Barlow DH, Allen LB, Choate ML. Toward a unified treatment for emotional disorders. Behav Therapy 2004; 35: 205-30.CrossRef
11.
Cooper Z, Fairburn CG: A new cognitive behavioural approach to the treatment of obesity. Beh Res Therapy 2001; 39: 499-511.CrossRef
12.
Craigle MA, Nathan P. A nonrandomized effectiveness comparison of broad-spectrum group CBT to individual CBT for depressed outpatients in a community mental health setting. Behav Therapy 2009; 40: 302-14.CrossRef
13.
Wing RR. Behavioral approaches to the treatment of obesity, In Bray GA, Bouchard C, James WPT (eds), Handbook of Obesity. New York: Marcel Dekker, 1998; 855-78.
14.
Wing RR, Jeffery RW. Benefits of recruiting participants with friends and increasing social support for weight loss and maintenance. J Consult Clin Psychol 1999; 67: 132-8.CrossRefPubMed
15.
Schneider KL, Bodenlos JS, Ma Y et al. Design and methods for a randomized clinical trial treating comorbid obesity and major depressive disorder. BMC Psychiatr 2008; 8: 77.CrossRef
16.
Simon GE, Ludman EJ, Linde JA et al. Association between obesity and depression in middle-aged women. Gen Hosp Psychiat 2008; 30: 32-9.CrossRef
17.
Spitzer R, Kroenke K, Williams J. Validation and utility of a self-report version of PRIME-MD: The PHQ primary care study. JAMA 1999; 282: 1737-44.CrossRefPubMed
18.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th ed.). Washington, DC: American Psychiatric Association; 1994.
19.
First M, Spitzer R, Gibbon M, Williams J. Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I), Clinician Version. Washington: American Psychiatric Press; 1997.
20.
Shear MK, Greeno C, Kang J et al. Diagnosis of nonpsychotic patients in community clinics. Am J Psychiatr 2000; 157: 581-7.CrossRefPubMed
21.
Derogatis L, Rickels K, Uhlenhuth EH, Covi L. The Hopkins Symptom Checklist: A measure of primary symptom dimensions. In: Pichot P, ed. Psychological Measurements in Psychopharmacology: Problems in Psychopharmacology. Basel, Switzerland: Kargerman; 1974: 79-110.
22.
Mulrow CD, Williams JW Jr, Gerety MB, Ramirez G, Montiel OM, Kerber C. Case-finding instruments for depression in primary care settings. Ann Intern Med 1995; 122: 913-21.PubMed
23.
Katon W, Robinson P, Von Korff M et al. A multifaceted intervention to improve treatment of depression in primary care. Arch Gen Psychiatr 1996: 53: 924-32.PubMed
24.
Simon GE, Von Korff M, Rutter C, Wagner E. A randomized trial of monitoring, feedback, and management of care by telephone to improve depression treatment in primary care. BMJ 2000; 320: 550-4.CrossRefPubMed
25.
Paffenbarger R, Wing A, Hyde R. Physical activity as an index of heart attack risk in college alumni. Am J Epidemiol 1978; 108: 161-75.PubMed
26.
Ainsworth BE, Haskell WL, Whitt MC et al. Compendium of Physical Activities: An update of activity codes and MET intensities. Med Sci Sport Exer, 2000; 32 (Suppl): S498-S516.CrossRef
27.
Harris JK, French SA, Jeffery RW, McGovern PG, Wing RR. Dietary and physical activity correlates of long-term weight loss. Obes Res 1994; 2: 307-13.PubMed
28.
Schakel SF. Procedures for estimating nutrient values for food composition databases. J Food Comp Anal 1997; 10: 102-14.CrossRef
29.
Schakel SF. Maintaining a nutrient database in a changing marketplace: Keeping pace with changing food products—A research perspective. J Food Comp Anal 2001; 14: 315-22.CrossRef
30.
Efron B. Forcing a sequential experiment to be balanced. Biometrika 1971; 58: 403-17.CrossRef
31.
Pocock SJ, Simon R. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics 1975; 31: 103-15.CrossRefPubMed
32.
Jeffery RW, Wing RR, Thorson C et al. Strengthening behavioral interventions for weight loss: A randomized trial of food provision and monetary incentives. J Consult Clin Psychol 1993; 61: 1038-45.CrossRefPubMed
33.
Jeffery RW, Wing RR, Thorson C, Burton LR. Use of personal trainers and financial incentives to increase exercise in a behavioral weight-loss program. J Consult Clin Psychol 1998; 66: 777-83.CrossRefPubMed
34.
Jeffery RW, Wing RR, Sherwood NE, Tate DF. Physical activity and weight loss: Does prescribing higher physical activity goals improve outcome? Am J Clin Nutr 2003; 78: 684-9.PubMed
35.
Wing RR, Jeffery RW, Burton LR, Thorson C, Nissinoff KS, Baxter JE. Food provision vs. structured meal plans in the behavioral treatment of obesity. Int J Obes 1996; 20: 56-62.
36.
Brown R, Lewinsohn P. A psychoeducational approach to the treatment of depression: Comparison of group, individual, and minimal contact procedures. J Consult Clin Psychol 1984; 52: 774-83.CrossRefPubMed
37.
Ludman EJ, Simon GE, Ichikawa L, et al. Does depression reduce the effectiveness of behavioral weight loss treatment? Behav Med 2009; 35: 126-134.CrossRef
38.
Cohen J. Statistical Power Analysis for the Behavioral Sciences (2nd ed.). Hillsdale NJ: Lawrence Erlbaum Associates; 1988.
39.
Arterburn D, Ichikawa L, Ludman EJ et al. Validity of clinical body weight measures as substitutes for missing data in a randomized trial. Obes Res Clin Pract 2008; 2: 277-81.CrossRefPubMed
40.
Paulose-Ram R, Safran MA, Jonas BS, Gu Q, Orwig D. Trends in psychotropic medication use among U.S. adults. Pharmacoepidemiol Drug Saf 2007; 16: 560-70.CrossRefPubMed
41.
Jeffery RW, Sherwood NE, Brelje K et al. Mail and phone interventions for weight loss in a managed-care setting: Weigh-to-be one-year outcomes. Int J Obes 2003; 27: 1584-92.CrossRef
42.
Andrews G. Placebo response in depression: Bane of research, boon to therapy. Br J Psychiatr 2001; 178: 192-94.CrossRef
43.
Butler AC, Beck AT. Cognitive therapy for depression. Clin Psychol 1995; 48: 3-5.
Metadaten
Titel
A Randomized Controlled Trial of Behavioral Weight Loss Treatment Versus Combined Weight Loss/Depression Treatment Among Women with Comorbid Obesity and Depression
verfasst von
Jennifer A. Linde, Ph.D.
Gregory E. Simon, M.D., M.P.H
Evette J. Ludman, Ph.D.
Laura E. Ichikawa, M.S
Belinda H. Operskalski, M.P.H
David Arterburn, M.D.
Paul Rohde, Ph.D.
Emily A. Finch, M.A
Robert W. Jeffery, Ph.D.
Publikationsdatum
01.02.2011
Verlag
Springer-Verlag
Erschienen in
Annals of Behavioral Medicine / Ausgabe 1/2011
Print ISSN: 0883-6612
Elektronische ISSN: 1532-4796
DOI
https://doi.org/10.1007/s12160-010-9232-2

Weitere Artikel der Ausgabe 1/2011

Annals of Behavioral Medicine 1/2011 Zur Ausgabe

Original Article

Domains of Chronic Stress, Lifestyle Factors, and Allostatic Load in Middle-Aged Mexican-American Women

Original Article

Disaggregating the Relationship Between Posttraumatic Stress Disorder Symptom Clusters and Chronic Orofacial Pain: Implications for the Prediction of Health Outcomes with PTSD Symptom Clusters

Original Article

Spirituality and Religiosity in Patients with HIV: A Test and Expansion of a Model

Original Article

Tailored Print Communication and Telephone Motivational Interviewing Are Equally Successful in Improving Multiple Lifestyle Behaviors in a Randomized Controlled Trial

Original Article

Education and Levels of Salivary Cortisol Over the Day in US Adults

Original Article

Exercise Interventions for Cancer Survivors: A Meta-Analysis of Quality of Life Outcomes

Neu in den Fachgebieten Neurologie und Psychiatrie

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Bildnachweise